Flonase Allergy Relief Nasal Spray, 24-Hour Non-Drowsy Multi-Symptom Relief, Bonus Pack of Tissues

Flonase Allergy Relief Nasal Spray, a 24-hour non-drowsy allergy medicine, provides comprehensive relief for individuals suffering from nasal congestion, runny nose, sneezing, itchy nose, and itchy, watery eyes (1). Containing the most prescribed allergy medication, fluticasone propionate (2), this spray offers powerful multisymptom relief from indoor and outdoor allergens, including pollen, mold, dust, and pet dander, making it an excellent choice for seasonal allergy sufferers.

As the number 1 doctor-recommended allergy brand (2), Flonase delivers long-lasting, full-strength relief from allergy symptoms, working year-round to address the needs of those affected by allergies. Users can administer up to two sprays in each nostril daily, with the included free bonus pack of tissues providing a convenient solution for managing sneezes and sniffles on the go.

Formulated for adults and children 4 years of age and older, Flonase Allergy Relief Nasal Spray is designed to block 6 allergic substances, thereby preventing the body's overreaction to allergens. This non-drowsy formula offers a versatile solution for individuals seeking relief during allergy season and throughout the year, whether it's for Spring, back-to-school, or the Fall.

The Flonase Allergy Relief Nasal Spray package includes a 144-spray bottle of the 24-hour non-drowsy allergy medicine, as well as a bonus pack of tissues and one package of 48ct Flonase Headache and Allergy Relief Caplets, providing a comprehensive solution for managing allergy-related symptoms.

With its powerful formula, long-lasting relief, and versatility in addressing a wide range of allergy-related issues, Flonase Allergy Relief Nasal Spray stands out as a trusted choice for individuals seeking to overcome the challenges posed by seasonal and year-round allergies.

(1) Flonase is indicated for itchy, watery eyes in adults and children 12 years of age and older. (2) Among OTC Allergy Medications based on IQVIA survey data for May 1, 2022, through April 30, 2023.

product information: